Company profile for AMAG Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicines for complex yet under-treated health conditions across a range of therapeutic areas including anemia, pregnancy complications, women’s sexual function and menopause-related issues. We also work with patients and healthcare experts to break down barriers to care for the communities we serve through focused education and support programs. AMAG...
Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicines for complex yet under-treated health conditions across a range of therapeutic areas including anemia, pregnancy complications, women’s sexual function and menopause-related issues. We also work with patients and healthcare experts to break down barriers to care for the communities we serve through focused education and support programs. AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs across a range of therapeutic areas all while delivering value to our shareholders.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1100 Winter Street Waltham, MA 02451
Telephone
Telephone
617.498.3300
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/amag-loses-insurance-claim-tied-manufacturing-snafu-pfizers-previously-trouble-mcpherson

FIERCE PHARMA
22 Aug 2024

https://www.fiercepharma.com/pharma/covis-granted-fda-hearing-latest-twist-over-controversial-premature-birth-med-makena

N. H. Dunn FIERCEPHARMA
21 Aug 2021

https://www.raps.org/news-and-articles/news-articles/2021/3/fda-unmoved-by-new-meta-analysis-still-recommends

Kari Oakes RAPS
30 Mar 2021

https://www.globenewswire.com/fr/news-release/2020/12/14/2144543/0/en/AMAG-Pharmaceuticals-Files-Submission-in-Response-To-the-Food-And-Drug-Administration-s-Notice-of-Opportunity-for-a-Hearing-and-Proposal-To-Withdraw-Approval-of-Makena-hydroxyproge.html

GLOBENEWSWIRE
14 Dec 2020

https://www.biospace.com/article/releases/covis-group-completes-acquisition-of-amag-pharmaceuticals/?s=79

BIOSPACE
16 Nov 2020

https://www.prnewswire.com/news-releases/covis-group-completes-acquisition-of-amag-pharmaceuticals-301173667.html

PRNEWSWIRE
16 Nov 2020

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty